go back

Arkansas rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $676,083 · 10th–90th $676,083–$707,9460%50%90th$676,083Professionalmedian $562,341 · 10th–90th $562,341–$676,0830%50%90th$562,341$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$676,082.98 / $676,082.98 / $707,945.78
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $676,082.98
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $562,341.33
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$389,045.14 / $537,031.80 / $758,577.58